Intellipharmaceutics International (IPCIF) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest Intellipharmaceutics International Short Interest DataIntellipharmaceutics International (IPCIF) has a short interest of 500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 12,042 shares to cover all short positions.Current Short Interest500 sharesPrevious Short Interest500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio5.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares33,093,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume12,042 sharesToday's Volume Vs. Average0% Short Selling Intellipharmaceutics International? Sign up to receive the latest short interest report for Intellipharmaceutics International and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPCIF Short Interest Over TimeIPCIF Days to Cover Over TimeIPCIF Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Intellipharmaceutics International Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024500 shares $0.00 No ChangeN/A5 $0.00 10/15/2024500 shares $0.00 No ChangeN/A0.2 $0.00 9/30/2024500 shares $0.00 No ChangeN/A5 $0.00 9/15/2024500 shares $0.00 No ChangeN/A5 $0.00 8/31/2024500 shares $0.00 No ChangeN/A0 $0.00 8/15/2024500 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for IPCIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024500 shares $0.00 No ChangeN/A0 $0.00 7/15/2024500 shares $0.00 -28.6%N/A0.3 $0.00 6/30/2024700 shares $52.50 -89.7%N/A0.5 $0.08 6/15/20246,800 shares $680.00 -74.6%N/A1 $0.10 5/31/202426,800 shares $570.84 +61.5%N/A6.7 $0.02 5/15/202416,600 shares $913.00 -5.7%N/A15.1 $0.06 4/30/202417,600 shares $1,056.00 -23.1%N/A0.7 $0.06 4/15/202422,900 shares $1,374.00 -19.9%N/A2.5 $0.06 3/31/202428,600 shares $2,035.18 +2,760.0%N/A1.2 $0.07 3/15/20241,000 shares $25.50 +100.0%N/A0.2 $0.03 2/29/2024500 shares $23.25 No ChangeN/A0.1 $0.05 2/15/2024500 shares $27.00 -84.9%N/A0.1 $0.05 1/15/20243,500 shares $177.45 +9.4%N/A0.2 $0.05 12/31/20233,200 shares $205.44 -61.5%N/A0.1 $0.06 12/15/20238,300 shares $605.07 +3.8%N/A1.5 $0.07 11/30/20238,000 shares $340.00 +166.7%N/A1.5 $0.04 11/15/20233,000 shares $161.40 No ChangeN/A3.8 $0.05 10/31/20233,000 shares $161.10 No ChangeN/A1.8 $0.05 10/15/20233,000 shares $210.00 No ChangeN/A0.1 $0.07 9/30/20233,000 shares $244.50 -6.3%N/A3.3 $0.08 9/15/20233,200 shares $228.80 -3.0%N/A0.6 $0.07 8/31/20233,300 shares $260.37 No ChangeN/A0.4 $0.08 8/15/20233,300 shares $312.18 +6.5%N/A0.2 $0.09 7/31/20233,100 shares $310.00 -62.7%N/A0.1 $0.10 7/15/20238,300 shares $397.57 No ChangeN/A1.4 $0.05 6/30/20238,300 shares $357.52 +1,560.0%N/A1.4 $0.04 6/15/2023500 shares $27.75 No ChangeN/A0 $0.06 5/31/2023500 shares $30.00 No ChangeN/A0.1 $0.06 5/15/2023500 shares $10.00 No ChangeN/A0 $0.02 4/30/2023500 shares $27.50 No ChangeN/A0.2 $0.06 4/15/2023500 shares $30.00 -88.9%N/A0.2 $0.06 3/31/20234,500 shares $243.23 +462.5%N/A0.3 $0.05 3/15/2023800 shares $44.80 -46.7%N/A0.2 $0.06 2/28/20231,500 shares $75.30 +7.1%N/A0.3 $0.05JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/15/20231,400 shares $85.40 +180.0%N/A0.6 $0.06 1/31/2023500 shares $37.08 No ChangeN/A0.4 $0.07 1/15/2023500 shares $44.50 No ChangeN/A0.3 $0.09 12/30/2022500 shares $35.10 -96.2%N/A0 $0.07 12/15/202213,200 shares $951.72 -5.0%N/A2.4 $0.07 11/30/202213,900 shares $1,000.80 -6.1%N/A2.3 $0.07 11/15/202214,800 shares $1,215.08 +5.7%N/A4.8 $0.08 10/31/202214,000 shares $1,142.40 +45.8%N/A2.4 $0.08 10/15/20229,600 shares $873.60 -25.6%N/A1.1 $0.09 9/30/202212,900 shares $1,056.51 -35.5%N/A1.3 $0.08 9/15/202220,000 shares $1,820.00 +29.0%N/A2.1 $0.09 8/31/202215,500 shares $1,376.40 +72.2%N/A7.8 $0.09 8/15/20229,000 shares $907.20 -71.0%N/A1.5 $0.10 7/31/202231,000 shares $3,180.60 -11.9%N/A3.2 $0.10 7/15/202235,200 shares $3,168.00 -12.0%N/A1.5 $0.09 6/30/202240,000 shares $3,720.00 +55.0%N/A3.8 $0.09 6/15/202225,800 shares $2,838.00 +529.3%N/A1.6 $0.11 5/31/20224,100 shares $492.00 +720.0%N/A0.6 $0.12 5/15/2022500 shares $62.85 -28.6%N/A0 $0.13 4/30/2022700 shares $87.50 -69.6%N/A0 $0.13 4/15/20222,300 shares $299.00 -51.1%N/A0.2 $0.13 3/31/20224,700 shares $614.76 -37.3%N/A0.5 $0.13 3/15/20227,500 shares $951.00 -24.2%N/A0.5 $0.13 2/28/20229,900 shares $1,270.17 +191.2%N/A1 $0.13 2/15/20223,400 shares $436.90 -22.7%N/A0.4 $0.13 1/31/20224,400 shares $501.60 No ChangeN/A0.4 $0.11 1/15/20224,400 shares $731.72 +83.3%N/A0.1 $0.17 12/31/20212,400 shares $301.20 +380.0%N/A0 $0.13 12/15/2021500 shares $42.80 -16.7%N/A0 $0.09 11/30/2021600 shares $72.00 +20.0%N/A0 $0.12 11/15/2021500 shares $64.95 No ChangeN/A0 $0.13 10/29/2021500 shares $74.25 No ChangeN/A0.1 $0.15 10/15/2021500 shares $65.00 No ChangeN/A0.1 $0.13 9/30/2021500 shares $67.50 -16.7%N/A0.1 $0.14 9/15/2021600 shares $81.42 -89.1%N/A0.2 $0.14 8/31/20215,500 shares $833.80 +189.5%N/A0.4 $0.15 8/13/20211,900 shares $316.73 +280.0%N/A0.2 $0.17 7/30/2021500 shares $88.55 -95.4%N/A0 $0.18 7/15/202110,800 shares $1,728.00 +145.5%N/A0.6 $0.16 6/30/20214,400 shares $797.28 -47.0%N/A0.2 $0.18 6/15/20218,300 shares $1,823.51 +361.1%N/A0.2 $0.22 5/28/20211,900 shares $345.42 +111.1%N/A0.3 $0.18 5/14/2021900 shares $173.52 -59.1%N/A0 $0.19 4/30/20212,200 shares $514.80 -81.7%N/A0.1 $0.23 4/15/202112,000 shares $2,764.80 +60.0%N/A0.3 $0.23 3/31/20217,500 shares $1,500.00 No ChangeN/A0.1 $0.20 3/15/20217,500 shares $1,500.00 -44.0%N/A0.1 $0.20 2/26/202113,400 shares $4,020.00 -22.5%N/A0.1 $0.30 2/12/202117,300 shares $5,440.85 -81.6%N/A0 $0.31 1/29/202194,000 shares $14,560.60 +45.1%N/A1.4 $0.15JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/15/20219,800 shares $1,568.00 +58.1%N/A0.5 $0.16 12/31/20206,900 shares $897.00 -29.6%N/A0.1 $0.13 12/15/20209,800 shares $1,412.18 +58.1%N/A0.5 $0.14 11/30/20206,200 shares $815.92 +933.3%N/A0.1 $0.13 11/15/2020600 shares $82.56 -78.6%N/A0 $0.14 10/30/20202,800 shares $446.60 -86.3%N/A0 $0.16 10/15/202020,400 shares $2,431.68 +827.3%N/A0.2 $0.12 9/30/20202,200 shares $264.00 +340.0%N/A0.1 $0.12 9/15/2020500 shares $64.50 -64.3%N/A0 $0.13 8/31/20201,400 shares $196.00 +7.7%N/A0.1 $0.14 8/14/20201,300 shares $183.04 -56.7%N/A0 $0.14 7/31/20203,000 shares $451.50 +150.0%N/A0.1 $0.15 7/15/20201,200 shares $170.64 -75.5%N/A0 $0.14 6/30/20204,900 shares $681.10 +880.0%N/A0.1 $0.14 6/15/2020500 shares $73.00 -91.9%N/A0 $0.15 5/29/20206,200 shares $845.68 -27.9%N/A0.1 $0.14 5/15/20208,600 shares $1,216.04 +405.9%N/A0.2 $0.14 4/30/20201,700 shares $266.22 -96.3%N/A0 $0.16 4/15/202045,300 shares $5,934.30 -71.6%N/A1.2 $0.13 3/31/2020159,700 shares $23,955.00 -40.5%N/A1 $0.15 3/13/2020268,200 shares $32,184.00 +10.3%N/A3 $0.12 2/28/2020243,100 shares $30,217.33 +0.8%N/A3.2 $0.12 2/14/2020241,200 shares $31,356.00 +7.4%N/A1.9 $0.13 1/31/2020224,500 shares $39,287.50 -50.1%N/A0.2 $0.18 1/15/2020449,600 shares $76,432.00 +157.7%N/A0.3 $0.17 12/31/2019174,500 shares $29,665.00 +101.0%N/A0.4 $0.17 IPCIF Short Interest - Frequently Asked Questions What is Intellipharmaceutics International's current short interest? Short interest is the volume of Intellipharmaceutics International shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 500 shares of IPCIF short. Learn More on Intellipharmaceutics International's current short interest. What is a good short interest ratio for Intellipharmaceutics International? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPCIF shares currently have a short interest ratio of 5.0. Learn More on Intellipharmaceutics International's short interest ratio. How does Intellipharmaceutics International's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Intellipharmaceutics International: Unity Biotechnology, Inc. (1.97%), MEI Pharma, Inc. (1.23%), ProPhase Labs, Inc. (0.65%), Cognition Therapeutics, Inc. (2.41%), Enlivex Therapeutics Ltd. (0.75%), Palatin Technologies, Inc. (6.23%), Bullfrog AI Holdings, Inc. (4.76%), Flora Growth Corp. (9.66%), Marinus Pharmaceuticals, Inc. (10.26%), Cara Therapeutics, Inc. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Intellipharmaceutics International stock? Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intellipharmaceutics International? A short squeeze for Intellipharmaceutics International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPCIF, which in turn drives the price of the stock up even further. How often is Intellipharmaceutics International's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPCIF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Unity Biotechnology Short Interest Data MEI Pharma Short Interest Data ProPhase Labs Short Interest Data Cognition Therapeutics Short Interest Data Enlivex Therapeutics Short Interest Data Palatin Technologies Short Interest Data Bullfrog AI Short Interest Data Flora Growth Short Interest Data Marinus Pharmaceuticals Short Interest Data Cara Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPCIF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
